nanoML TM is our revolutionary pre-clinical R&D platform that harnesses the combined knowledge of the nanotechnology, biology, and AI. We empower scientists across therapeutic areas to personalize therapeutic formulations at any R&D stage. The nanoML TM analytics platform extracts, indexes, and displays the formulation and experimental data from peer-reviewed publications. Scientists can design, screen, and compare the performance of their therapeutic formulations to accelerate pre-clinical R&D. Enhance the R&D speed and increase the yield of your portfolio exponentially, not incrementally. Unleashing the power of nanotechnology Leverage experimental data to accelerate the R&D of your nanoformulations.
